WallStreetZenWallStreetZen

NASDAQ: ORMP
Oramed Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Oramed Pharmaceuticals earnings were $43.9M for the trailing 12 months ending Sep 30, 2025, with 836.4% growth year over year. The latest ORMP earnings report on Sep 30, 2025 announced Q3 2025 earnings of $48.4M, up 264.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ORMP reported annual earnings of -$19.1M, with -445% growth. The next ORMP earnings date is Feb 25, 2026.

ORMP past earnings growth

How has ORMP's earnings growth performed historically?

Company
836.36%
Industry
60.1%
Market
53.75%
ORMP's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ORMP's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ORMP's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ORMP earnings history

Current Revenue
$2.0M
Current Earnings
$43.9M
Current Profit Margin
2,192.6%

ORMP Return on Equity

Current Company
27.2%
Current Industry
-21.2%
Current Market
35.1%
ORMP's Return on Equity (27.2%)... subscribe to Premium to read more.
High Return on Equity Performance

ORMP undefined

Current Company
25.6%
Current Industry
-8.8%
ORMP is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ORMP announces earnings.

ORMP undefined

Current Company
20.05%
Current Industry
-3.4%
ORMP has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ORMP vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ORMP$43.10M$43.85M+836.36%$1.03
OTLK-$63.58M-$62.42MN/A-$1.79
SLGLN/AN/AN/AN/A
FBIO$21.58M-$5.34MN/A-$0.11
FATE-$141.44M-$156.09MN/A-$1.33
View Top Biotech Stocks

ORMP earnings dates

Next earnings date
Feb 25, 2026

Oramed Pharmaceuticals Earnings Reports & History FAQ

What were Oramed Pharmaceuticals's earnings last quarter?

On ORMP's earnings call on Invalid Date, Oramed Pharmaceuticals (NASDAQ: ORMP) reported Q3 2025 earnings per share (EPS) of $1.16, up 341.67% year over year. Total ORMP earnings for the quarter were $48.40 million. In the same quarter last year, Oramed Pharmaceuticals's earnings per share (EPS) was -$0.48.

If you're new to stock investing, here's how to buy Oramed Pharmaceuticals stock.

When does Oramed Pharmaceuticals report earnings?

The next ORMP earnings call is Invalid Date. Add ORMP to your watchlist to be reminded of Oramed Pharmaceuticals's next earnings date.

Is Oramed Pharmaceuticals profitable or losing money?

As of the last Oramed Pharmaceuticals earnings report, Oramed Pharmaceuticals is currently profitable. Oramed Pharmaceuticals's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $43.85 million, a 882.13% increase year over year.

What was ORMP's earnings growth in the past year?

As of Oramed Pharmaceuticals's earnings date in Invalid Date, Oramed Pharmaceuticals's earnings has grown 836.36% year over year. This is 776.27 percentage points higher than the US Biotechnology industry earnings growth rate of 60.1%. ORMP earnings in the past year totalled $43.85 million.

What are Oramed Pharmaceuticals's earnings expectations?

The current EPS estimate for Oramed Pharmaceuticals's earnings report in Invalid Date is -$0.08.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.